Keyphrases
5-azacytidine
10%
Antineoplastic Drugs
100%
Biochemical Approaches
10%
Breast Cancer Cells
10%
Cancer Cells
100%
Cancer Stage
10%
Caveolin-1 (Cav-1)
100%
Chemotherapy
10%
Colon Cancer Cells
30%
Cytotoxic Drugs
10%
Drug Concentration
20%
Drug Resistance
10%
Enhanced Migration
10%
Epigenetic Mechanisms
10%
Epigenetic Repression
10%
Epigenetics
10%
ERK Activation
10%
Genetic Approach
10%
In Cancer
10%
MEK-ERK
10%
Metastasis
100%
Metastatic Cells
10%
Metastatic Potential
20%
Methyltransferase Inhibitor
10%
Migration Invasion
100%
Non-lethal
10%
Rac1
10%
ROS Production
10%
Scaffold Protein
10%
Signaling Events
10%
Signaling Pathway
10%
Src Kinase
10%
Subtherapeutic Concentrations
10%
Tissue Availability
10%
Tumor Suppressor
10%
Medicine and Dentistry
Anticarcinogen
100%
Azacitidine
10%
Breast Cancer
10%
Cancer Cell
100%
Caveolin 1
100%
Colon Cancer
30%
Cytotoxic Agent
10%
Drug Resistance
10%
Epigenetic Mechanism
10%
Epileptic Absence
10%
In Vitro
30%
Malignant Neoplasm
10%
Metastasis Potential
20%
Metastatic Carcinoma
100%
Methyltransferase Inhibitor
10%
Protein Tyrosine Kinase
10%
Reactive Oxygen Species
10%
Scaffold Protein
10%
Signal Transduction
10%
Tumor Suppressor Protein
10%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
100%
Azacitidine
10%
Breast Cancer
10%
Caveolin 1
100%
Chemotherapy
10%
Colon Cancer
30%
Cytotoxic Agent
10%
Drug Concentration
20%
Drug Resistance
10%
Epileptic Absence
10%
Malignant Neoplasm
100%
Metastasis
10%
Metastasis Potential
20%
Methyltransferase Inhibitor
10%
Protein Tyrosine Kinase
10%
Scaffold Protein
10%
Tumor Suppressor Protein
10%
Biochemistry, Genetics and Molecular Biology
Azacitidine
10%
Cancer Cell
100%
Caveolin 1
100%
Colon
30%
Drug Concentration
20%
Drug Resistance
10%
Epigenetic Mechanism
10%
Epigenetics
20%
Genetics
10%
Methyltransferase
10%
Receptor Tyrosine Kinase
10%
Scaffold Protein
10%
Signal Transduction
10%
Transcription
10%
Tumor Suppressor Protein
10%